ArticleVaccines2024

Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults with Underlying Medical Conditions in the United States.

Hagit Kopel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.